checkAd

     261  0 Kommentare IDEXX Laboratories to Release 2023 Second Quarter Financial Results

    IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 second quarter results for Tuesday, August 1, 2023 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.

    Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q2 2023 Earnings Snapshot through a link on the IDEXX website, www.idexx.com/investors. An archived edition of the webcast will be available after 1:00 p.m. ET on that day via the same link and will remain available for one year.

    Anzeige 
    Handeln Sie Ihre Einschätzung zu IDEXX Laboratories!
    Long
    473,69€
    Basispreis
    3,36
    Ask
    × 12,40
    Hebel
    Short
    549,91€
    Basispreis
    4,20
    Ask
    × 9,00
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    The live call also will be accessible by telephone. To listen to the live conference call, please dial 1-877-612-6725 or 1-773-305-6837 and reference passcode 351415.

    2023 Investor Day

    IDEXX Laboratories, Inc. will host its 2023 Investor Day on Thursday, August 10, 2023 at its corporate headquarters in Westbrook, Maine from approximately 8:00 am to 12:00 pm (ET). A live webcast of the presentations will be available on www.idexx.com/investors. Advance registration for the in-person event is required; institutional investors and analysts interested in attending should contact investorrelations@idexx.com. Additional information on IDEXX’s Investor Day will be provided closer to the date of the event.

    About IDEXX Laboratories

    IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500 Index. Headquartered in Maine, IDEXX employs nearly 11,000 people and offers solutions and products to customers in more than 175 countries. For more information about IDEXX, visit www.idexx.com.


    The IDEXX Laboratories Stock at the time of publication of the news with a fall of -0,23 % to 490,2USD on Nasdaq stock exchange (29. Juni 2023, 20:45 Uhr).


    Business Wire (engl.)
    0 Follower
    Autor folgen

    IDEXX Laboratories to Release 2023 Second Quarter Financial Results IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 second quarter results for Tuesday, August 1, 2023 before the market opens. The Company will conduct an analyst conference …